SI-BONE, Inc. (SIBN) Market Cap & Valuation Ratios
SI-BONE, Inc. (SIBN) has a market cap of $962.7M and a price-to-sales ratio of 4.5, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SIBNSI-BONE, Inc.Follow SIBN — free
—
Price chart with a free account
- Market cap
- 962.7M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
Peers
medical devices · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| SIBN | 1.0 | — | 4.5 | — | -0.5% | +15% | -8% | -10% |
| PRCT | 1.1 | — | 2.9 | — | -7.4% | +23% | -34% | -77% |
| AORT | 1.1 | — | 3.0 | 31.5 | -0.8% | +16% | 4% | 2% |
| IRMD | 1.1 | 47.9 | 12.0 | 35.6 | 2.2% | +11% | 32% | 51% |
| CBLL | 1.0 | — | 9.1 | — | -5.3% | +32% | -69% | -52% |
| QDEL | 0.9 | — | 1.4 | — | — | -2% | -31% | -17% |
| IART | 0.9 | — | 1.5 | 10.8 | 9.3% | +0.8% | 4% | 2% |
| INMD | 0.9 | 9.8 | 1.3 | 5.8 | 9.5% | -6% | 23% | 19% |
| BBNX | 0.9 | — | 5.7 | — | -7.1% | +53% | -70% | -35% |
| AHCO | 0.8 | — | 0.8 | 9.0 | 11.9% | -0.4% | -4% | -4% |
| VREX | 0.8 | — | 1.2 | 10.3 | -2.6% | +5% | 8% | 8% |
| Median of these 10 | 28.9 | 2.2 | 10.5 | -0.8% | +8% | 0.0% | -1% |
; EV/Sales 4.5 vs. 2.2.
Growth vs. price
each dot a company · hover or tap for valuesSI-BONE, Inc. — questions
- What is SI-BONE, Inc.'s market cap?
- $962.7M.
- What is SI-BONE, Inc.'s price-to-sales ratio?
- 4.5.
Every figure on this page comes from SI-BONE, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.